Implement these initiatives, said Cramer, and the stock market would rocket to all-time highs and America would be on a much more solid footing with a far brighter future.
Executive DecisionIn the "Executive Decision" segment, Cramer spoke with Chris Garabedian, president and CEO of Sarepta Therapeutics ( SRPT), a small biotech firm that saw its shares soar over 200% after the company announced Wednesday positive data for its muscular dystrophy drug, Eteplirsen. Cramer recommended Sarepta as a speculative stock back on Sept. 21. Garabedian said his company is very excited about today's news and the market's response to it, as well as what the data mean to patients and their families. He then showed a chart of how patients taking Eteplirsen fared against those taking a placebo over a 48-week period. The data clearly showed those patients taking the placebo saw a steady progression of the disease until they were no longer able to walk, but those taking Eteplirsen not only stabilized but actually saw improvement in weeks 36 through 48. Sarepta has now switched those taking the placebo to Eteplirsen and is studying how the drug affects people in the later stages of the disease. Garabedian explained that while the data only include Phase II results and the sample size was 12 patients, this is not uncommon for a rare disease. What matters most is how much patients improved while taking the drug. He also responded to criticisms that two patients did not respond to the drug. He said in those cases the disease had already started progressing before the drug could take hold. Garabedian said Sarepta is amenable to taking on partners to help it speed up its Eteplirsen program and expand it overseas, but the company is also preparing to continue developing the drug in-house if necessary. Cramer said results like these don't come from a paycheck, or a bank CD or even a typical stock, they only come from speculating, which is why he has always said that speculation needs to be a part of everyone's portfolio.
What's in FashionIn a second "Executive Decision" segment, Cramer sat down with Eric Wiseman, chairman, president and CEO of VF Corp ( VFC), the apparel maker that's seen its shares rise 55% since Cramer last spoke with Wiseman in April 2011. Wiseman said outdoor apparel remains a big driver for VF Corp, whether it be boots, socks or jackets. He said his company's acquisition of the Timberland brand in June 2011 is part of that strategy and VF looks to reintroduce Timberland apparel in the U.S. market by the fall of next year. When asked about VF's terrific portfolio of brands, Wiseman commented that VF now has 30 brands in its stable, and while not every one performs well in every market, the diversity gives it many opportunities such as investing in its North Face brand in Germany and Vans in the U.K. Turning to the company's retail strategy, Wiseman acknowledged some of its retail customers were leery of the company opening factory stores around the corner, but the company has learned that as more stores open the brands become stronger for all of their customers. Among the other positives at VF are the falling price of cotton, which is a big component in denim, as well as currencies around the world turning in the company's favor. Cramer said the VF story remains intact, adding that with a great company and great management, "sometimes it is just that easy."
Lightning RoundHere's what Cramer had to say about callers' stocks during the "Lightning Round": Salesforce.com ( CRM): "I feel even better about Salesforce and how things are going over there." Waste Management ( WM): "You're being paid to wait while the construction market picks up." Enterprise Products Partners ( EPD): "I think this one is terrific." Universal Health Services ( UHS): "I believe in this company. It's one of the best health care REITs. I also like Health Care REIT ( HCN) at $59." Westport Innovations ( WPRT): "Very speculative situation. I believe in it but it's highly speculative. " Cisco Systems ( CSCO): "I think the stock could go to $21 and not have its valuation stretched."
Walt Disney ( DIS): "With gasoline going down, Disney remains a buy. " Stillwater Mining ( SWC): "No. I like the SPDR Gold Shares ( GLD)."